Completeness of Open Access FluNet Influenza Surveillance Data for Pan-America in 2005-2019

Overview

Journal Sci Rep

Specialty Science

Date 2021 Jan 13

PMID 33437025

Citations 10

Authors

Ryan B Simpson

Jordyn Gottlieb

Bingjie Zhou

Meghan A Hartwick

Elena N Naumova

Affiliations

Soon will be listed here.

Abstract

For several decades, the World Health Organization has collected, maintained, and distributed invaluable country-specific disease surveillance data that allow experts to develop new analytical tools for disease tracking and forecasting. To capture the extent of available data within these sources, we proposed a completeness metric based on the effective time series length. Using FluNet records for 29 Pan-American countries from 2005 to 2019, we explored whether completeness was associated with health expenditure indicators adjusting for surveillance system heterogeneity. We observed steady improvements in completeness by 4.2-6.3% annually, especially after the A(H1N1)-2009 pandemic, when 24 countries reached > 95% completeness. Doubling in decadal health expenditure per capita was associated with ~ 7% increase in overall completeness. The proposed metric could navigate experts in assessing open access data quality and quantity for conducting credible statistical analyses, estimating disease trends, and developing outbreak forecasting systems.

Citing Articles

Global seasonal and pandemic patterns in influenza: An application of longitudinal study designs.

Naumova E, Simpson R, Zhou B, Hartwick M Int Stat Rev. 2024; 90(Suppl 1):S82-S95.

PMID: 38607896 PMC: 9874745. DOI: 10.1111/insr.12529.

Determining the timing of respiratory syncytial virus (RSV) epidemics: a systematic review, 2016 to 2021; method categorisation and identification of influencing factors.

Staadegaard L, Duckers M, van Summeren J, van Gameren R, Demont C, Bangert M Euro Surveill. 2024; 29(5).

PMID: 38304952 PMC: 10835753. DOI: 10.2807/1560-7917.ES.2024.29.5.2300244.

The impact of the SARS-CoV-2 pandemic on global influenza surveillance: Insights from 18 National Influenza Centers based on a survey conducted between November 2021 and March 2022.

Staadegaard L, Riccio M, Wiegersma S, El Guerche-Seblain C, Dueger E, Akcay M Influenza Other Respir Viruses. 2023; 17(5):e13140.

PMID: 37180840 PMC: 10173050. DOI: 10.1111/irv.13140.

Forecasting Hospital Visits Due to Influenza Based on Emergency Department Visits for Fever: A Feasibility Study on Emergency Department-Based Syndromic Surveillance.

Hong S, Son W, Park B, Choi B Int J Environ Res Public Health. 2022; 19(19).

PMID: 36232253 PMC: 9566228. DOI: 10.3390/ijerph191912954.

Role of cross-reactivity in cellular immune targeting of influenza A M1 variant peptide epitopes.

Petrova G, Naumov Y, Naumova E, Gorski J Front Immunol. 2022; 13:956103.

PMID: 36211433 PMC: 9539824. DOI: 10.3389/fimmu.2022.956103.

References

Fefferman N, Naumova E . Innovation in observation: a vision for early outbreak detection. Emerg Health Threats J. 2012; 3:e6. PMC: 3167656. DOI: 10.3134/ehtj.10.006. View

Polansky L, Outin-Blenman S, Moen A . Improved Global Capacity for Influenza Surveillance. Emerg Infect Dis. 2016; 22(6):993-1001. PMC: 4880096. DOI: 10.3201/eid.2206.151521. View

Flahault A, Chaberty P, Esteves K, Valleron A, Lavanchy D . FluNet as a tool for global monitoring of influenza on the Web. JAMA. 1998; 280(15):1330-2. DOI: 10.1001/jama.280.15.1330. View

Saunders-Hastings P, Krewski D . Reviewing the History of Pandemic Influenza: Understanding Patterns of Emergence and Transmission. Pathogens. 2016; 5(4). PMC: 5198166. DOI: 10.3390/pathogens5040066. View

Moorthy M, Castronovo D, ABraham A, Bhattacharyya S, Gradus S, Gorski J . Deviations in influenza seasonality: odd coincidence or obscure consequence?. Clin Microbiol Infect. 2012; 18(10):955-62. PMC: 3442949. DOI: 10.1111/j.1469-0691.2012.03959.x. View

Caini S, Andrade W, Badur S, Balmaseda A, Barakat A, Bella A . Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination?. PLoS One. 2016; 11(3):e0152310. PMC: 4816507. DOI: 10.1371/journal.pone.0152310. View

Chaiyakunapruk N, Kotirum S, Newall A, Lambach P, Hutubessy R . Rationale and opportunities in estimating the economic burden of seasonal influenza across countries using a standardized WHO tool and manual. Influenza Other Respir Viruses. 2017; 12(1):13-21. PMC: 5818351. DOI: 10.1111/irv.12491. View

de Francisco Shapovalova N, Donadel M, Jit M, Hutubessy R . A systematic review of the social and economic burden of influenza in low- and middle-income countries. Vaccine. 2015; 33(48):6537-44. DOI: 10.1016/j.vaccine.2015.10.066. View

Caini S, Alonso W, Balmaseda A, Bruno A, Bustos P, Castillo L . Characteristics of seasonal influenza A and B in Latin America: Influenza surveillance data from ten countries. PLoS One. 2017; 12(3):e0174592. PMC: 5367818. DOI: 10.1371/journal.pone.0174592. View

10.

Uyeki T, Bernstein H, Bradley J, Englund J, File T, Fry A . Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Clin Infect Dis. 2018; 68(6):e1-e47. PMC: 6653685. DOI: 10.1093/cid/ciy866. View

11.

Johnson L, Muir-Paulik S, Kennedy P, Lindstrom S, Balish A, Aden T . Capacity building in national influenza laboratories--use of laboratory assessments to drive progress. BMC Infect Dis. 2015; 15:501. PMC: 4636816. DOI: 10.1186/s12879-015-1232-1. View

12.

Wenger J, Naumova E . Seasonal synchronization of influenza in the United States older adult population. PLoS One. 2010; 5(4):e10187. PMC: 2855366. DOI: 10.1371/journal.pone.0010187. View

13.

Brammer L, Budd A, Cox N . Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems. Influenza Other Respir Viruses. 2009; 3(2):51-8. PMC: 4634524. DOI: 10.1111/j.1750-2659.2009.00077.x. View

14.

Ortiz J, Perut M, Dumolard L, Wijesinghe P, Jorgensen P, Ropero A . A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization. Vaccine. 2016; 34(45):5400-5405. PMC: 5357765. DOI: 10.1016/j.vaccine.2016.07.045. View

15.

Prager F, Wei D, Rose A . Total Economic Consequences of an Influenza Outbreak in the United States. Risk Anal. 2016; 37(1):4-19. DOI: 10.1111/risa.12625. View

16.

Stohr K . The global agenda on influenza surveillance and control. Vaccine. 2003; 21(16):1744-8. DOI: 10.1016/s0264-410x(03)00065-3. View

17.

Lofgren E, Wenger J, Fefferman N, Bina D, Gradus S, Bhattacharyya S . Disproportional effects in populations of concern for pandemic influenza: insights from seasonal epidemics in Wisconsin, 1967-2004. Influenza Other Respir Viruses. 2010; 4(4):205-12. PMC: 2951388. DOI: 10.1111/j.1750-2659.2010.00137.x. View

18.

Lofgren E, Fefferman N, Naumov Y, Gorski J, Naumova E . Influenza seasonality: underlying causes and modeling theories. J Virol. 2006; 81(11):5429-36. PMC: 1900246. DOI: 10.1128/JVI.01680-06. View

19.

Monto A . Reflections on The Global Influenza Surveillance and Response System (GISRS) at 65 Years: An Expanding Framework for Influenza Detection, Prevention and Control. Influenza Other Respir Viruses. 2018; 12(1):10-12. PMC: 5818347. DOI: 10.1111/irv.12511. View